Skip to content

Section archive

Weight Loss Pill

The European Medicines Agency told doctors to stop prescribing the weight loss drug sibutramine, concluding its heart risks outweigh the benefits. The FDA said in November 2009 it was reviewing data suggesting patients on the drug had more heart attacks, strokes and cardiac arrests.

1 min read

1 story